Untargeted Metabolomics and Metabolite–Gene Network Analysis Predict NF-κB Inhibition in Artemisian B-Treated Triple-Negative Breast Cancer Cells
Metabolites · 28.05.2026 · 16 (6) · 365
DOI: 10.3390/metabo16060365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 28.05.2026. Verfasst von Shujun Shan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing 210094, China. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Triple-negative breast cancer (TNBC) remains a formidable clinical challenge due to the scarcity of targeted therapies and profound metabolic heterogeneity. Although Artemisian B, a dimeric sesquiterpene lactone derived from Artemisia argyi, exhibits potent antiproliferative activity, its comprehensive metabolic footprint and the translation of these perturbations into downstream signaling regulation remain poorly characterized.
Methods
To address this gap, we employed an integrative analytical framework combining untargeted metabolomics, topology-guided metabolite–gene network mapping, and parallel experimental validation in MDA-MB-231 cells. This workflow systematically profiled cellular phenotypes, global metabolic reprogramming, and key signaling nodes, enabling the prioritization of high-confidence mechanistic links between metabolic alterations and signal transduction.
Results
Artemisian B dose-dependently suppressed TNBC cell viability (IC50 = 12.12 μM) and triggered mitochondrial apoptosis, characterized by Bax upregulation, Bcl-2 downregulation, and caspase-9/3 activation. Untargeted metabolomics identified 129 significantly altered metabolites, reflecting extensive dysregulation across lipid peroxidation, bioenergetics, and nucleotide metabolism. Topological analysis of the metabolite–gene network identified the NF-κB pathway as a highly interconnected hub within this perturbed landscape. Parallel experimental validation corroborated this prediction, demonstrating that Artemisian B consistently suppressed the phosphorylation of IKKα/β, IκBα, and p65, while markedly attenuating p65 nuclear translocation.
Conclusions
Artemisian B induces TNBC apoptosis through extensive metabolic reprogramming coupled with concurrent inhibition of NF-κB signaling. By seamlessly integrating untargeted metabolomics with network topology, our framework not only successfully bridges metabolic perturbations with signaling outcomes but also establishes a versatile, dual-perspective strategy applicable to both biochemical reaction networks and signal transduction pathways. This approach provides a robust predictive paradigm for decoding the multi-target pharmacological mechanisms of natural products.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing 210094, China.
- Department of Pharmaceutical Engineering, Jiangsu Provincial Xuzhou Pharmaceutical Vocational College, Xuzhou 221116, China.
- College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
ORCID-Profile: Junsong Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shan, S., Hu, Z., Xue, G., Yao, P., Du, P., Gan, R., & Wang, J. (2026). Untargeted Metabolomics and Metabolite–Gene Network Analysis Predict NF-κB Inhibition in Artemisian B-Treated Triple-Negative Breast Cancer Cells. Metabolites, 16(6), 365. https://doi.org/10.3390/metabo16060365
Vancouver
Shan S, Hu Z, Xue G, Yao P, Du P, Gan R, et al. Untargeted Metabolomics and Metabolite–Gene Network Analysis Predict NF-κB Inhibition in Artemisian B-Treated Triple-Negative Breast Cancer Cells. Metabolites. 2026;16(6):365. doi:10.3390/metabo16060365
BibTeX
@article{Shan2026,
author = {Shan, Shujun and Hu, Ziyun and Xue, Guimin and Yao, Ping and Du, Peipei and Gan, Ruixi and Wang, Junsong},
title = {Untargeted Metabolomics and Metabolite–Gene Network Analysis Predict NF-κB Inhibition in Artemisian B-Treated Triple-Negative Breast Cancer Cells},
journal = {Metabolites},
year = {2026},
volume = {16},
number = {6},
pages = {365},
doi = {10.3390/metabo16060365}
}
EUVIMED